<< Read Full Article
<< Read Full Article
The Daily Interview: GenomicsFund.com's Steve Newby
The (GENEX Quote)GenomicsFund.com has the singular distinction of being the only pure-play genomics mutual fund out there. It also had the dubious distinction of being one of the worst-performing health care funds over the past year, and was especially hard-hit this past Monday, dropping 12.8% that day alone.
| Steven Newby Fund Manager GenomicsFund.com |
| Recent Daily Interviews |
|
Harvard University's Samuel L. Hayes |
|
Matthews Japan Fund's Mark Headley |
|
Gerard Klauer Mattison's Michael Cristinziano |
|
Standard & Poor's Megan Graham-Hackett |
|
Merrill Lynch Investment Managers' Terry K. Glenn |
Despite the fund's poor performance since its inception a year ago, portfolio manager Steven Newby maintains that the biotechnology sector could end up delivering spectacular returns over the long term. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,285.81 | 1,092.34 | 2,169.57 | 33.69 |
Oil *
75.60
|
|
DOWN
104.30
|
DOWN
10.91
|
DOWN
20.04
|
DOWN
0.79
|
10 Yr
3.37%
SPDR Gold
112.44
|
|
-1.00%
|
-0.99%
|
-0.92%
|
-2.29%
|
Data delayed 20 minutes |


Connect with TheStreet